Crystal Digital PCR® Assay for NRAS (Q61K, drop-off Q61)

Supplier: STILLA TECHNOLOGIES, INC.

New Product

Certificates

Supplier: STILLA TECHNOLOGIES, INC.

New Product

About this item

Assay-specific Crystal Flex Probes and primers for the detection of NRAS mutations and its positive control. NRAS (Q61K, drop-off Q61) Crystal Digital PCR® Assay is a 10X assay designed to detect and quantify mutations in Q61 plus 1 mutation of the NRAS gene. NRAS is pivotal in regulating cell signaling pathways implicated in cancer development, notably melanoma and colorectal cancer.

Ready-to-use assay reagents to detect multiple targets in a single reaction
Crystal Flex Probe detection chemistry for flexible assay configuration
Same set of crystal universal reporters to detect any target in different assays

Wet lab tested
Compatibility: Nio™ Digital PCR, Prism6, Prism3, ruby chip
Channels: Green, blue, red
Required reagents: Crystal universal reporter 3 and naica® PCR MIX 10X
Target: NRAS Q61/Q61K

Caution: For research use only. Not for use in diagnostic procedures.

Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

• State issued document with your organization's Federal Tax ID Number
• State issued document with your organization's Resale Tax ID Number
• City or County issued Business License
• State Department of Health Services License
• Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.